Ftse Mib
33.986,90
1,06%
DAX
18.175,21
1,01%
S&P 500
5.180,74
1,03%
NASDAQ
16.349,25
1,19%
Bitcoin
63.871,70
1,12%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Oncocyte Corporation (OCX) Oncocyte Corporation (OCX) Notizie

Oncocyte Corporation

OCX
2,77
0,11 (4,14%)
07 Mag 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
12/4/202412:00GLOBEOncocyte Reports Full Year 2023 Financial Results
12/4/202403:46GLOBEOncocyte Corporation Announces $15.8 Million Private..
11/4/202423:30GLOBEOncocyte and Bio-Rad Partner on Global Launch of Transplant..
09/4/202422:05GLOBEOncocyte to Announce Fourth Quarter and Full Year 2024..
23/1/202422:39EDGAR2Form 8-K - Current report
16/1/202414:00GLOBEOncocyte to Present at the Sequire Investor Summit in Puerto..
06/12/202314:00GLOBEOncocyte Begins FDA Submissions Process for VitaGraft..
09/11/202323:19EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/11/202313:05EDGAR2Form 8-K - Current report
09/11/202313:00GLOBEOncocyte Reports Third Quarter 2023 Financial Results
03/11/202313:30GLOBEOncocyte to Announce Third Quarter 2023 Financial Results
12/10/202322:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/10/202322:48EDGAR2Form 8-K/A - Current report: [Amend]
05/10/202322:05EDGAR2Form 8-K - Current report
20/9/202315:00EDGAR2Form 8-K - Current report
28/8/202322:05EDGAR2Form 8-K - Current report
18/8/202300:57EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/8/202322:50EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10/8/202313:05EDGAR2Form 8-K - Current report
25/7/202315:08GLOBEVitaGraft Kidney Expands Utility in Recurrent Primary..
24/7/202323:28EDGAR2Form 8-K - Current report
24/7/202319:35GLOBEOncocyte Announces 1-For-20 Reverse Stock Split
21/7/202323:16EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
14/7/202312:03EDGAR2Form 8-K - Current report
10/7/202317:20EDGAR2Form DEF 14A - Other definitive proxy statements
04/7/202300:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/6/202322:14EDGAR2Form PRE 14A - Other preliminary proxy statements
29/6/202322:05EDGAR2Form 8-K - Current report
27/6/202314:30GLOBEOncocyte Begins Manufacturing Transplant Blood Test
11/5/202314:00GLOBEOncocyte Reports First Quarter 2023 Financial Results
Apertura: 2,69 Min: 2,59 Max: 2,84
Chiusura: 2,66

La tua Cronologia

NASDAQ
OCX
Oncocyte
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network